Search details
1.
New directions in clinical trials for frontotemporal lobar degeneration: Methods and outcome measures.
Alzheimers Dement
; 16(1): 131-143, 2020 01.
Article
in English
| MEDLINE | ID: mdl-31668596
2.
Quality of life and caregiver burden in familial frontotemporal lobar degeneration: Analyses of symptomatic and asymptomatic individuals within the LEFFTDS cohort.
Alzheimers Dement
; 16(8): 1115-1124, 2020 08.
Article
in English
| MEDLINE | ID: mdl-32656921
3.
The longitudinal evaluation of familial frontotemporal dementia subjects protocol: Framework and methodology.
Alzheimers Dement
; 16(1): 22-36, 2020 01.
Article
in English
| MEDLINE | ID: mdl-31636026
4.
The role of neurofilament light in genetic frontotemporal lobar degeneration.
Brain Commun
; 5(1): fcac310, 2023.
Article
in English
| MEDLINE | ID: mdl-36694576
5.
Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration.
Neurology
; 96(18): e2296-e2312, 2021 05 04.
Article
in English
| MEDLINE | ID: mdl-33827960
6.
Peripheral Innate Immune Activation Correlates With Disease Severity in GRN Haploinsufficiency.
Front Neurol
; 10: 1004, 2019.
Article
in English
| MEDLINE | ID: mdl-31620075
7.
Tracking white matter degeneration in asymptomatic and symptomatic MAPT mutation carriers.
Neurobiol Aging
; 83: 54-62, 2019 11.
Article
in English
| MEDLINE | ID: mdl-31585367
8.
An 8-week, open-label, dose-finding study of nimodipine for the treatment of progranulin insufficiency from GRN gene mutations.
Alzheimers Dement (N Y)
; 3(4): 507-512, 2017 Nov.
Article
in English
| MEDLINE | ID: mdl-29124108
9.
SGS742: the first GABA(B) receptor antagonist in clinical trials.
Biochem Pharmacol
; 68(8): 1479-87, 2004 Oct 15.
Article
in English
| MEDLINE | ID: mdl-15451390
Results
1 -
9
de 9
1
Next >
>>